Therefore, the clinical utility of serum AIMP1 could be emphasized by the fact that it could serve as a complementary index for predicting severe AAV, independently of ESR, CRP, and ANCA levels. The gene discussed is AIMP1; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.